You are here: Industry Insights > NIH

News List

US NIH to launch international alliance for Covid-19 drugs and vaccine pharmaceutical-technology
April 21, 2020
The US National Institutes of Health (NIH) is set to launch a public-private partnership, which will bring together health agencies and pharmaceutical companies to accelerate Covid-19 drugs and vaccines.
FDA COVID-19 Update contractpharma
April 21, 2020
Public-private partnership with the FDA and others aims to speed the development of COVID-19 vaccine and treatment options.
NIH Launches Clinical Trial of Hydroxychloroquine for COVID-19 drugs
April 10, 2020
A clinical trial to assess the antimalarial drug hydroxychloroquine as a treatment for adults with the novel coronavirus (COVID-19) is now underway.
Amydis Awarded NIH Grant for Cerebral Amyloid Angiopathy americanpharmaceuticalreview
September 24, 2019
Amydis has received a Phase 2A SBIR grant award from the National Institute on Aging of the National Institutes of Health (NIH).
Soligenix Announces NIH Small Business Innovation Research Award americanpharmaceuticalreview
August 16, 2019
Soligenix announced the National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health (NIH), has awarded Soligenix a Phase I Small Business Innovation Research (SBIR) of
NIH publishes largest genomic study on type 2 diabetes in sub-Saharan African populations biospectrumasia
July 23, 2019
Researchers show critical association between diabetes and previously unlinked ZRANB3 gene
IDT Biologika Awarded New NIH Task Order contractpharma
July 18, 2019
Part of 10-year NIH contract to manufacture vaccines and biologics for infectious diseases.
NIH launches large TB prevention trial biospectrumasia
June 28, 2019
A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuberculosis (MDR-TB) has begun. The study is comparing the safety and efficacy of a new MDR-TB drug, delamanid, with the decades-old TB dru
Calidi Biotherapeutics Announces Collaborative Study with NIH americanpharmaceuticalreview
May 29, 2019
Calidi Biotherapeutics announced their ongoing scientific collaboration with David F. Stroncek, M.D., Chief, Cell Therapy Section at the Department of Transfusion Medicine ...
NIH awards T3D Therapeutics $9m to fund a trial of its lead product pharmaceutical-technology
May 23, 2019
US-based T3D Therapeutics has announced it has received a $9m grant over four years from the US National Institutes of Health (NIH)’s National Institute of Aging to support its Phase II clinical trial of its lead candidate T3D-959 in Alzheimer’s disease.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page